Clinicopathological and immunohistochemical analysis of malignant features in mucinous cystic tumors of the pancreas

Hepato-Gastroenterology

Volumn 53, Issue 68, 2006, Pages 286-290

  Sawai, Hirozumi ^a   Okada, Yuji ^a   Funahashi, Hitoshi ^a   Matsuo, Yoichi ^a   Hayakawa, Tetsushi ^a   Tanaka, Moritsugu ^a   Takeyama, Hiromitsu ^a   Manabe, Tadao ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Immunohistochemistry; Integrins; Interleukin 1 receptor type I; Mucinous cystic tumors; p53 protein; Pancreatic neoplasm

Indexed keywords

ALPHA6 INTEGRIN; CYCLINE; INTERLEUKIN 1 RECEPTOR; PROTEIN P53; VERY LATE ACTIVATION ANTIGEN 6;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CYSTADENOCARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MUCINOUS CARCINOMA; OVARY CYST; PANCREAS CYST; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CLASSIFICATION;

ADULT; AGED; AGED, 80 AND OVER; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOMA, MUCINOUS; FEMALE; HUMANS; INTEGRIN ALPHA5BETA1; INTEGRIN ALPHA6; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE I; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33645579622     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Warshaw AL, Compton CC, Lewandrowsli K, Cardenosa G, Mueller PR: Cystic tumor of the pancreas. Ann Surg 1990; 212:432-445.
2. Taft DA, Freeny PC: Cystic neoplasms of the pancreas. Am J Surg 1981; 142:30-35.
3. Klöppel G, Solcia E, Longnecker DS, Cappella C, Sobin LH: Histological typing of tumores of the exocrine pancreas. World Health Organization. International histological classification of tumors. 2nd Edition. Berlin: Springer, 1996; pp. 11-21.
4. Compagno J, Oertel JE: Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma): A clinicopathological study of 41 cases. Am J Clin Pathol 1978; 69:573-580.
5. Fukushima N, Mukai K, Kanal Y, Hasebe T, Shimada K, Ozaki H, Kinoshita T, Kosuge T: Intraductal papillary tumors and mucinous cystic tumors of the pancreas: Clinicopathologic Study of 38 cases. Hum Pathol 1997; 28:1010-1017.
6. Becker WF, Welch RA, Pratt HS: Cystadenoma and cystadenocarcinoma of the pancreas. Ann Surg 1965; 161:845-863.
7. Albores-Saavedra J, Angeles-Angeles A, Nadji M, Henson DE, Alverez L: Mucinous cystadenocarcinoma of the pancreas: morphologic and immunocytochemical observations. Am J Surg Pathol 1987; 11:11-20.
8. Hodgkinson DJ, ReMine WH, Weiland LH: Pancreatic cystadenoma: a clinicopathologic study of 45 cases. Arch Surg 1987; 113:512-519.
9. Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, Pellegata NS, Ranzani GN, Rickaert F, Klöppel G: Intraductal papillary-mutinous tumors represent a distinct group of pancreatic neoplasms: an investigation of tumor cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virch Arch 1994; 425:357-367.
10. Z'graggen K, Rivera JA, Compton CC, Pins M, Werner J, Fernandez-del Castillo C, Rattner DW, Lewandrowski KB, Rustgi AK, Warshaw AL: Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997; 226:491-500.
11. Yamada M, Kozuka S, Yamano K, Nakazawa S, Haitoh Y, Tsukamoto Y: Mucin-producing tumors of the pancreas. Cancer 1991; 68:159-168.
12. Loftus EV Jr., Olivares-Pakzad BA, Batts KP, Adkins MC, Stephens DH, Sarr MG, DiMagno EP: Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology 1996; 110:1909-1918.
13. Sugiyama M, Atomi Y, Kuroda A: Two types of mucin-producing cystic tumors of the pancreas: diagnosis and treatment. Surgery 1997; 122:617-625.
14. Lan H, Zain R, Saitoh M, Muramatsu Y, Shrestha P, Mori M: Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa - a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness? Anticancer Res 1996; 16:3059-3066.
15. Kawahira H, Kobayashi S, Kaneko K, Asano T, Ochiai T: p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. Hepatogastroenterology 2000; 47:973-977.
16. Sawai H, Yamamoto M, Okada Y, Sato M, Akamo Y, Takeyaraa H, Manabe T: Alteration of integrins by Interleukin-1α in human pancreatic cancer cells. Pancreas 2001; 23:399-405.
17. Sawai H, Funahashi H, Matsuo Y, Yamamoto M, Okada Y, Hayakawa T, Manabe T: Expression and prognostic roles of integrins and interleukin-1 receptor type I in patients with ductal adenocarcinoma of the pancreas. Dig Dis Sci 2003; 48:1241-1250.
18. Jean LG., Therese T, Stratis A: The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979; 27:1131-1139.
19. Gary SW, Roger W: Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 1981; 29:1196-1204.
20. Japan Pancreatic Society: Classification of Pancreatic Cancer, 1st English Edition. Tokyo, Kanehara, 2003; pp. 27-38.
21. Shimizu Y, Yasui K, Yamao K, Ohhashi K, Kato T, Yamamura Y, Hirai T, Kodera Y, Kanemitsu Y, Ito S, Yanagisawa A: Possiple oncogenesis of mucinous cystic tumors of the pancreas lacking ovarian-like stroma. Pancreatology 2002; 2:413-420.
22. Albores-Saavendra J, Gould EW, Angeles-Angeles A, Henson DE: Cystic tumors of the pancreas. Pathol Annu 1990; 25:19-50.
23. Thompson LDR, Becker RC, Przygodzki RM, Adair CF, Heffes CS: Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathological study of 130 cases. Am J Surg Pathol 1999; 23:1-16.
24. Warren KW, Hardy KJ: Cystadenocarcinoma of the pancreas. Surg Gynecol Obstet 1968; 127:734-736.
25. Lan H, Zain R, Saitoh M, Muramatsu Y, Shrestha P, Mori M: Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa - a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness? Anticancer Res 1996; 16:3059-3066.
26. Kawahira H, Kobayashi S, Kaneko K, Asano T, Ochiai T: p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy. Hepatogastroenterology 2000; 47:973-977.